Although the role of TNF-α on vascular impairments has been reported, the novel findings of the current study revealed that anti-TNF-α treatment abrogated obesity-induced vascular dysfunction in rats by suppressing inflammation, indicating that anti-inflammatory agents might be considered as a candidate for treatment of cardiovascular disorders associated with obesity. Here, TNF is linked to obesity due to melanocortin 4 receptor deficiency.